Wellgistics Health Inc WGRX 深 沪
已收盘 04-02 16:00:00 美东时间
0.1015
-0.005
-5.14%
华盛通- 最 高0.1123
- 今 开0.107
- 成交量 112.09万股
- 最 低 0.1002
- 昨 收 0.107
- 总市值 1064.45万
- 52周最高 7.04
- 市盈率 静 --
- 换手率 1.07%
- 52周最低 0.0954
- 委 比 -96.08%
- 总股本 1.05亿
- 历史最高 7.04
- 量 比 0.65
- 振 幅 11.31%
- 历史最低 0.0954
- 每 手 1
- 风险率 1.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Are Shares Of Wellgistics Health Falling?
Shares of Wellgistics Health Inc. are trading lower after announcing a letter of intent to evaluate the acquisition of Neuritek Therapeutics.
03-24 01:23
Wellgistics Health Signs $105M Non-Binding All-Stock LOI For Potential Neuritek Acquisition
Wellgistics Health, Inc. ("Wellgistics" or the "Company") (NASDAQ:WGRX) today announced that it has entered into a non-exclusive, non-binding Letter of Intent ("LOI") to evaluate a potential acquisition of Neuritek
03-23 21:07
Wellgistics Health signs LOI to evaluate USD 105 million acquisition of Neuritek Therapeutics
Wellgistics Health signs LOI to evaluate USD 105 million acquisition of Neuritek Therapeutics Wellgistics entered a non-exclusive, non-binding letter of intent to evaluate a potential acquisition of Neuritek Therapeutics. The proposed transaction is an all-stock deal with an indicated value of USD 1
03-23 21:07
Wellgistics Health Plans Shift to Direct-to-Patient Online Pharmacy, Expand EinsteinRx and PharmacyChain Platforms, and Develop Telemedicine, Diagnostics and Partner Ecosystem for Patient Care Coordination
Wellgistics Health Plans Shift to Direct-to-Patient Online Pharmacy, Expand EinsteinRx and PharmacyChain Platforms, and Develop Telemedicine, Diagnostics and Partner Ecosystem for Patient Care Coordination Wellgistics Health Inc. said it plans to shift its focus toward selling prescription drugs and
03-13 21:00
Wellgistics Health Plans to Develop PharmacyChain Smart-Contract Drug Tracking on Multiple Blockchain Platforms and Target In-Pharmacy Deployment by Q2 2026, with Broader Rollout to Its Pharmacy Network Later in 2026
Wellgistics Health Plans to Develop PharmacyChain Smart-Contract Drug Tracking on Multiple Blockchain Platforms and Target In-Pharmacy Deployment by Q2 2026, with Broader Rollout to Its Pharmacy Network Later in 2026 Wellgistics Health Inc. said it plans to develop its PharmacyChain smart contracts-
03-05 20:40
Wellgistics Health Completes Strategic Investment In San Francisco Mental Health AI Startup Post‑Beta Testing
Previously announced partnership with Tollo Health subsidiary TolloCare adding telehealth service offering to drive Wellgistics Pharmacy prescription drug dispending of GLP-1 drugs and promote patient engagement via
02-18 20:43
Wellgistics Health Completes Strategic Investment in Stealth Mental Health AI Startup
Wellgistics Health Completes Strategic Investment in Stealth Mental Health AI Startup Wellgistics Health Inc. (NASDAQ: WGRX) completed a strategic minority equity investment in a San Francisco-based stealth mental health AI startup that has finished beta testing and is nearing service launch. The co
02-18 20:40
Wellgistics Health Secures Agreement with NFL Alumni Health to Expand Healthcare Programs
Wellgistics Health Secures Agreement with NFL Alumni Health to Expand Healthcare Programs Wellgistics Health Inc. announced that it has entered into an agreement with NFL Alumni Health to establish healthcare and wellness programs utilizing its proprietary EinsteinRx AI pharmacy dispensing platform
02-09 21:30
Wellgistics Health Announces Resignations of Two Board Directors
The latest update is out from Wellgistics Health Inc ( ($WGRX) ). On February 1...
02-06 06:56
Wellgistics Health Inc. Directors Steven Lee and Howard Doss Resign
Wellgistics Health Inc. Directors Steven Lee and Howard Doss Resign Wellgistics Health Inc. announced that Steven Lee and Howard Doss have resigned from the board of directors, effective immediately. Steven Lee was a member of the Ethics Committee, and Howard Doss served as chairman of the Audit Com
02-06 06:21
